Detalles de la búsqueda
1.
Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib.
Value Health
; 14(6): 846-51, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21914504
2.
Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
Neurosci Lett
; 425(2): 105-9, 2007 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-17826910
3.
Review of US Comparative Economic Evidence for Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line VEGF Inhibitor Therapy.
Am Health Drug Benefits
; 6(5): 275-86, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24991363
4.
International practice patterns and resource utilization in the treatment of neuroendocrine tumors.
Pancreas
; 42(2): 339-47, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357923
5.
United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment.
World J Gastroenterol
; 19(15): 2348-54, 2013 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23613628
6.
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States.
J Med Econ
; 15 Suppl 1: 55-64, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22881362
Resultados
1 -
6
de 6
1
Próxima >
>>